GLENMEDE TRUST CO NA - INTERPACE DIAGNOSTICS GROUP ownership

INTERPACE DIAGNOSTICS GROUP's ticker is IDXG and the CUSIP is 46062X204. A total of 15 filers reported holding INTERPACE DIAGNOSTICS GROUP in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of INTERPACE DIAGNOSTICS GROUP
ValueSharesWeighting
Q3 2019$6,000
+20.0%
7,9700.0%0.00%
Q2 2019$5,000
-16.7%
7,9700.0%0.00%
Q1 2019$6,0000.0%7,9700.0%0.00%
Q4 2018$6,000
-50.0%
7,9700.0%0.00%
Q3 2018$12,000
+50.0%
7,9700.0%0.00%
Q1 2018$8,0000.0%7,9700.0%0.00%
Q4 2017$8,000
-33.3%
7,9700.0%0.00%
Q3 2017$12,000
-40.0%
7,9700.0%0.00%
Q2 2017$20,0000.0%7,9700.0%0.00%
Q1 2017$20,000
-42.9%
7,9700.0%0.00%
Q4 2016$35,0007,9700.00%
Other shareholders
INTERPACE DIAGNOSTICS GROUP shareholders Q1 2018
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,839,708$1,624,0000.10%
LINCOLN CAPITAL CORP 10,350$9,0000.01%
WEDBUSH SECURITIES INC 53,000$47,0000.01%
NORTHERN TRUST CORP 26,258$23,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 84,995$75,0000.00%
CIBC Private Wealth Group, LLC 200$00.00%
CREDIT SUISSE AG/ 13,000$11,0000.00%
MORGAN STANLEY 615$1,0000.00%
BlackRock Inc. 1,158,352$1,022,0000.00%
Cambridge Investment Research Advisors, Inc. 22,600$20,0000.00%
View complete list of INTERPACE DIAGNOSTICS GROUP shareholders